AMF Tjanstepension AB Increases Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

AMF Tjanstepension AB raised its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 93.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 106,356 shares of the company’s stock after acquiring an additional 51,508 shares during the period. AMF Tjanstepension AB’s holdings in HCA Healthcare were worth $31,928,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the company. Legacy Investment Solutions LLC purchased a new position in shares of HCA Healthcare during the third quarter valued at approximately $39,000. Capital Performance Advisors LLP bought a new position in shares of HCA Healthcare in the third quarter worth about $41,000. Whipplewood Advisors LLC purchased a new stake in HCA Healthcare in the 4th quarter valued at about $31,000. Activest Wealth Management raised its stake in shares of HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after acquiring an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. grew its stake in HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after purchasing an additional 50 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently weighed in on HCA shares. Truist Financial decreased their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Royal Bank of Canada decreased their price objective on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. Cantor Fitzgerald reissued an “overweight” rating and issued a $405.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. Bank of America decreased their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, January 27th. Finally, KeyCorp cut their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $385.67.

Insider Buying and Selling

In related news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. This represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.60% of the stock is owned by insiders.

HCA Healthcare Stock Up 2.6 %

HCA Healthcare stock opened at $330.11 on Friday. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The business’s 50-day moving average price is $316.70 and its 200 day moving average price is $347.69. The firm has a market cap of $81.98 billion, a price-to-earnings ratio of 15.03, a price-to-earnings-growth ratio of 1.10 and a beta of 1.64.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the firm earned $5.90 EPS. As a group, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.87%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio is presently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.